XT-101: a novel and potent non-opioid treatment for neuropathic pain
Ended Cooperative Agreement Awarded Last action
- Award ID
- U44NS071642
- Recipient
-
Xalud Therapeutics, Inc. UEI LVJKCZJKEKV3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $2,847,606
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- San Francisco, CA 94110, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $216,354 | |
| Amendment | $383,748 | |
| Amendment | $951,688 | |
| Amendment | $996,485 | |
| Original award | $299,331 |
Quick answers
Who received award U44NS071642?
U44NS071642 was awarded to Xalud Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on June 15, 2011.
How much is award U44NS071642 worth?
$2,847,606 has been obligated on U44NS071642.
Which agency awarded U44NS071642?
National Institutes of Health (Department of Health and Human Services) awarded U44NS071642, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award